AZK names new executive managing director

Published: 2009-04-10 06:56:00

Updated: 2009-04-10 06:56:00

AstraZeneca Korea said that former Lilly Korea Vice President Lee In-hee, 46, was appointed as the new executive managing director to lead its Specialty Care unit (oncology and psychiatry) as well as strategic planning.

It said Lee’s mission is to fuel organic growth and build stronger local c...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK